Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tests Rapidly Detect Bleeding and Clotting

By HospiMedica staff writers
Posted on 12 Jul 2006
Two coagulation tests are designed for use in the diagnosis of bleeding and clotting disorders.

Oxoid Ltd (Basingstoke, UK) has extended its range of rapid diagnostic tests to include two coagulation tests. More...
The D-Dimer test and the Thrombo-Wellcotest detect either primary or secondary activation of the fibrinolytic system. Increased levels of fibrinogen or fibrin degradation products are found in conditions such as thromboembolic disease, myocardial infarction, post-operative vein thrombosis, disseminated intravascular coagulation, glomerulonephritis, and certain pregnancy disorders.

D-Dimer detects cross-linked fibrin degradation products, which are markers for secondary fibrinolysis, in plasma or serum. The Thrombo-Wellcotest detects fibrin or fibrinogen degradation products in serum or urine, greatly elevated levels of which are associated with all kinds of thrombotic episodes. When the two tests are used together, they offer a positive predictive value of almost 100%.

These rapid latex agglutination tests provide qualitative or semi-quantitative results within three minutes, ensuring prompt diagnosis and optimal patient care. They are extremely quick and simple to perform and readily fit into routine laboratory testing, saving time and laboratory resources. Results are clearly visible and easy to interpret in normal light, without the need for specialized equipment.



Related Links:
Oxoid

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.